An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort study

Table 4 Types of OAT reported by participants at any time point

	Methadone	Buprenorphine	Sustained release oral morphine (Kadian)	Other
Number of respondents on this type of OAT (%)	36/62 (58%)	17/62 (27%)	6/62 (10%)	3/62 (5%) (1 on extended release morphine (M-Eslon), 1 on depot buprenorphine (Sublocade), 1 on injectable OAT)

ISSN: 1747-597X